Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Sep;87(17):6487-91.
doi: 10.1073/pnas.87.17.6487.

Interleukin 1 is an autocrine regulator of human endothelial cell growth

Affiliations

Interleukin 1 is an autocrine regulator of human endothelial cell growth

F Cozzolino et al. Proc Natl Acad Sci U S A. 1990 Sep.

Abstract

Proliferation of endothelial cells is regulated through the autocrine production of growth factors and the expression of cognate surface receptors. In this study, we demonstrate that interleukin 1 (IL-1) is an inhibitor of endothelial growth in vitro and in vivo. IL-1 arrested growing, cultured endothelial cells in G1 phase; inhibition of proliferation was dose dependent and occurred in parallel with occupancy of endothelial surface IL-1 receptors. In an angiogenesis model, IL-1 could inhibit fibroblast growth factor-induced vessel formation. The autocrine nature of the IL-1 effect on endothelial proliferation was demonstrated by the observation that occupancy of cell-surface receptors by endogenous IL-1 depressed cell growth. The potential significance of this finding was emphasized by the detection of IL-1 in the native endothelium of human umbilical veins. A mechanism by which IL-1 may exert its inhibitory effect on endothelial cell growth was suggested by studies showing that IL-1 decreased the expression of high-affinity fibroblast growth factor binding sites on endothelium. These results point to a potentially important role of IL-1 in regulating blood vessel growth and suggest that autocrine production of inhibitory factors may be a mechanism controlling proliferation of normal cells.

PubMed Disclaimer

References

    1. J Immunol. 1988 Nov 1;141(9):3106-10 - PubMed
    1. Science. 1983 Nov 11;222(4624):623-5 - PubMed
    1. Science. 1986 Sep 5;233(4768):1078-80 - PubMed
    1. J Exp Med. 1985 Oct 1;162(4):1223-35 - PubMed
    1. J Immunol. 1985 Sep;135(3):1872-7 - PubMed

Publication types

MeSH terms

LinkOut - more resources